Expression of major vault protein gene in osteosarcoma patients

Journal of Orthopaedic Research

Volumn 25, Issue 7, 2007, Pages 958-963

  Dalla Torre, Cristiane Arruda ^a   de Toledo, Silvia Regina Caminada ^a   Yoshimoto, Maisa ^b   Petrilli, Antônio Sérgio ^a   Duffles Andrade, Joyce Anderson ^a   Chilton MacNeill, Susan ^c   Squire, Jeremy A ^b,d   Zielenska, Maria ^c,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Drug resistance; Gene expression; MVP gene; Osteosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; LUNG RESISTANCE PROTEIN;

ARTICLE; CANCER ADJUVANT THERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DNA MICROARRAY; FEMALE; GENE OVEREXPRESSION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; INFANT; MALE; METASTASIS; MULTIDRUG RESISTANCE; OSTEOSARCOMA; PHARMACOGENETICS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INFANT; MALE; NEOADJUVANT THERAPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 34447262364     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20371     Document Type: Article

References (18)

1. Link MP, Gebhardt MC, Meyers PA. 2002. Osteosarcoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 4th ed. Philadelphia: Lippincott William & Wilkins; p 1051-1089.
2. Instituto Brasileiro de Geografia e Estatística. Censo Demográfico 2000. http://www.ibge.gov.br
3. Petrilli AS, Camargo B, Odone VF, et al. for the BOTG. 2006. Results of the Brazilian osteosarcoma treatment group (BOTG) studies III and IV: prognostic factors and impact on survival. J Clin Oncol (in press).
4. Wada T, Isu K, Takeda N, et al. 1996. A preliminary report of neoadjuvant chemotherapy NSII-7 study in osteosarcoma: preoperative salvage chemotherapy based on clinical tumor response and the use of granulocyte colony-stimulating factor. Oncology 53:221-227.
5. Gorlick R, Meyers PA. 2003. Osteosarcoma necrosis following chemotherapy: innate biology versus treatment-especific. J Pediatr Hematol Oncol 25:840-841.
6. Takeshita H, Kusuaki K, Ashihara T, et al. 2000. Intrinsic resistance to chemotherapeutic agents in Murine osteosarcomas cells. JBJS 2:963-976.
7. Scheffer GL, Wijngaard PL, Flens MJ, et al. 1995. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1:578-582.
8. Gottesman MM, Fojo T, Bates SE. 2002. Multidrug resistance in cancer: role of atp-dependent transporters. Nat Rev Cancer 2:48-58.
9. Stephen AG, Raval-Fernandes S, Huynh T, et al. 2001. Assembly of vault-like particles in insect cells expressing only the major vault protein. J Biol Chem 276:23217-23220.
10. Mossink MH, Zon AV, Scheper RJ, et al. 2003. Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 22:7458-7467.
11. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
12. Liu ET. 2003. Classification of cancers by expression profiling. Curr Opin Genet Dev 13:97-103.
13. Knudson AG. 2001. Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157-162.
14. Huvos AG, Rosen G, Marcove RC. 1977. Primary osteogenic sarcoma. Pathologic aspects in 2 patients after treatment with chemotherapy, in bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 101: 14-18.
15. Ambudkar SV, Dey S, Hrycyna CA, et al. 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361-398.
16. Mintz MB, Sowers R, Brown KM, et al. 2005. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Res 65:1748-1754.
17. Man T-K., Chintagumpala M, Visvanatham J, et al. 2005. Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res 65:8142-8150.
18. Kruh GD. 2003. Introduction to resistance to anticancer agents. Oncogene 22:7262-7264.